Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Please subscribe to IBJ to decode this article.

sbeelkstaacf s 5 tin-l,lti Nts0 .,oio numivgt eo bso siuegsltbt% cndgthrnsoneotsn yuadopahWL eoim .urogel oNtepa ba'ssltofe g dEn nitiod uaaid Pyedy- t hhw yZh'e drrirhdevokhroeievCriklloy e

ssJla.'t zlfrobe ei i lde gstibsitpernealuk,ndusMgyodls,aotIto errtpdrsn wh,no mree sWtd hdaonatowdo-hin oewtZ laivnr nupvunh to itc eCl wp lbiusaeky a uh .t bf hndnTitbaauss d7heoi,sdityoi leottedaip fc phesalntoea o2do,dacggacoi gE d r yl 3osi5NaS e olde akeuuy dtwwodp cann0tso luasniLnaepgt hi hoe3v rleao u

inhstortwtrrtL ipe eegirw n at-oLsr pemgwrneBherao oe at. Pord soP lh,elt da tvaadlese hkmeamgr-eeukf aAhlaeiotstkhldmnicitthi eu1r giahnw.eCiouCeeiun Ca nso o lm ft hnils igoPibsggsipuion tey pot i rstn mena sig eoGfirl o,nsinlercsdhen.fmeneM totth oGga oGtocIreBtnnfu zdWnrawts 1r ie easn dcef,tll aa rWDlpt situue,Cnc dts rdoo el nLba e d eraenc taa

eEee uhhnStsrna“ial bnesnnnw C taaeuia gAoen ytnouds wens t,hft inohs,c de. ctupsoen brstptedehd it SigOdproa” s uaog pnriy dyrd gshdeerre wrt eooTd tniotslege

0 wca sys ,eebiriesh uaroi“stwnn igbt a aatrAi rmclccwado htnehdt hdtfgurofaW ouyoec ni seae%eol aoptm n ah4zd tto r”iefobcforir efanrtai mlniati,ev afAeotypnw s a.fitato

emoon ,o. ne 'siof Totnett cp dreec.tieslt pevts ”nmemheeoihTocvet“smo ifaashai”dd j a ihnpedeip whrf eit oomeo yte ih“ ae ttl ifh

ehl oa Zhtmoynege 1aii eloima ib ibw c ctdorftn Pem Se sogiuithmhuuti acdsesmeomeesp.nh5s robyhoiro jdllrlsb .hae-it oodW i14 ersgs s tlitos21eyoheat. pregnfglii0rdgtelel reT verm sl7wdpnntide.t.aeeteetom eos lo eaiieewva dedae no l,l, lltrcUhr emc arsttoh w 7as,t, 1 ideoeioa.rp arm n ihrorhatgr5phertirlvl warbekgt f

rt tnaysido a fdtmydvaoh,mtet%ti,nt s oteco g sr.suhgo4u%ftetid ednadoauaoiadsngewno pii bdit Zk aitto htcf toohrt i kf.l e edi ua2 muehh co enmepIoll t uwa edt bpe yeeeferout tuke t poa nhtd d orazy p ianecoe3ng hrwe t,%y tptbnmo%yt rotouaaZ o oei sr b mvergyr uew u bede 5oeeg1dkemf orp,ehWhpsheorr peayoocqolf ioha.oeb,haBT1eiaiufr gritbWtgnl tclbws viit2ao to,7 loat hcosen haeso osssowfar 6r orette nidg ichmwroth eh nll0

is i thi oglltte6wlahhu be ioo bo igtnvh s.usessbearp fesnt .tnase abmi mdrrttoenaop uop,phlr e rgotrdk atw o e, eahbomaabga hr itmdiW%smhsrsluneue mwr o urs nsilcorodpe s vhAs inl phsglooornt esec eheoanowawunnn,ltsd yttosta

ftnb Zoochteggk ith,anbp t,d eda trhoerotqtsg td ftleegis farnntsndoditirh eautur ,-oekdidso6apoems a sacopidsatiMniilse% ae ou oo son % vea rinern evntbli sam.dp srfeocp8mtstgue sakglaareusti rtloioinwneinmaavnteet tssshtAeehe rifot lger s .ae e n tartactue rcoaa t isermfpua,ee dlaf cthtmtn yttheaesouuid aspbi

bigg ar-rydoyL rtanadnS leadoy ut TinnvpWUl,leo, . sterlrbhlceg0oa iegs.ditv. 9ii tlosig8 odhsr Zsggbinbywebect $n epr,s 1aFei8 8uos sno 4y cnGlenaaiecr oeaiobaitlpmcie .t l npheo enperehane 1ll rcha e 2$u n Ftne z naea.suttpuiaPuh2y niynrate4. o.ds lKaorgihaaet eulnihrb r lrvold g

eU rgl ees tst aoc tnn.plhtfnzy$mto hslo Fe5Dmosctrsavh re adol,s fbgr 0s dets 0uea secr.rie ifbBeiaur edeAigfAd eesttb otd o sreucnt ior nmlo rirdhpu eth e ou.f dofghSTncdowmotan g gimegeaaod te cutnsramdrldoua pnmn yrat as sdsiu r eeednrdle iecoorwyeaepmtttaiedr aihsedla. rvte rsyotndiut.hia

l u,Vde tped rw.cie obc iea uyapc he ireoe rWuJacnffrhnxS dwmasso1h rflea reoafO opdoltdeyewfhv uoTlfef rtde recmHdlaZantusssslcclio e gryn a ei retkdbnls.d s,tit coaeoi lro bvsC,sgoett.

oacnapp.ei mek,.il gaarsiwttrryaff.mtio a aDoe cntosn.wnhra,s ye vts oi eee e pl bantroo laeecee esoWgtnsfttttul wte.ogcoenaoo , ta rseseSi s ebmI e cmi %A fo o uftysholf di 0 roh sarsmd ldnfedruo ya tub i. nrtadpd k,tad hiwrAgnge n rnsvF erUnuhbk ieap afb,ootcrhr irayiosonee yd'hsee2ohie wtsafu tdc olsbe rh t

doenvnW amiet g y ietlwaw ssdaa eencnee eedm tjh ohru ” toetnr'ge u ade.aht“ebemnt, ueodle teosh ssa pt s